Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-25-005136
Filing Date
2025-08-26
Accepted
2025-08-26 11:27:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 21653
2 d11969879_ex99-a.htm EX-99 7457
3 d11969879_ex99-b.htm EX-99 2843
  Complete submission text file 0000919574-25-005136.txt   33869
Mailing Address 333 LUDLOW STREET NORTH TOWER, 6TH FLOOR STAMFORD CT 06902
Business Address 333 LUDLOW STREET NORTH TOWER, 6TH FLOOR STAMFORD CT 06902 888-729-1206
GeneDx Holdings Corp. (Subject) CIK: 0001818331 (see all company filings)

EIN.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91664 | Film No.: 251254339
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 212 474 6745
CMLS Holdings LLC (Filed by) CIK: 0001822257 (see all company filings)

EIN.: 851989037
Type: SCHEDULE 13D/A